跳至主要内容
临床试验/CTRI/2024/02/062608
CTRI/2024/02/062608尚未招募2 期

A Randomized Standard Controlled Clinical Trial To Evaluate The Effect Of A3BM Tablet In Type II Diabetes Mellitus - Nil

Dr Nirali Hemantbhai Solanki0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with Classical signs and symptoms of Prameha and Madhumeha and Fasting Plasma Glucose (FPG) level =140 mg/dl and/or 2-hour (Postprandial) Plasma Glucose level
  • =180 mg/dl.

排除标准

  • 1.Patient’s age is below 30 years and above 60 years.
  • 2.Patients with T2DM who are insulin dependent and with severe diabetic complications like
  • cardiovascular diseases, nephropathy and retinopathy.
  • 3.Patients of Diabetes mellitus Type – 1 (Juvenile Diabetes).
  • 4.Patient having any other known malignancies or any other serious illness.
  • 5.Pregnant and lactating women.

研究者

发起方
Dr Nirali Hemantbhai Solanki

相似试验

Effect Of Ayurvedic Herbal Formulation (A3BM Tablet)... | 临床试验